Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focuses
Guide to authors
Online submissionOnline submission
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
Reprints and permissions
About this site
For librarians
 
NPG Resources
Nature
Nature Reviews
Nature Immunology
Nature Cell Biology
Nature Genetics
news@nature.com
Nature Conferences
Dissect Medicine
NPG Subject areas
Biotechnology
Cancer
Chemistry
Clinical Medicine
Dentistry
Development
Drug Discovery
Earth Sciences
Evolution & Ecology
Genetics
Immunology
Materials Science
Medical Research
Microbiology
Molecular Cell Biology
Neuroscience
Pharmacology
Physics
Browse all publications
Article
Nature Medicine  2, 347 - 350 (1996)
doi:10.1038/nm0396-347

Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH

James R. Burke1, 5, 8, Jan J. Enghild2, Margaret E. Martin1, 5, Yuh-Shan Jou6, Richard M. Myers6, Allen D. Roses1, 3, 5, Jeffery M. Vance1, 4, 5, 7 & Warren J. Strittmatter1, 3, 5, 7

  1Department of Medicine (Neurology), Duke University Medical Center, Durham, North Carolina 27710, USA

  2Department of Pathology, Duke University Medical Center, Durham, North Carolina 27710, USA

  3Department of Neurobioiogy, Duke University Medical Center, Durham, North Carolina 27710, USA

  4Department of Genetics, Duke University Medical Center, Durham, North Carolina 27710, USA

  5Deane Laboratory, Duke University Medical Center, Durham, North Carolina 27710, USA

  6Department of Genetics, Stanford University School of Medicine, Stanford, California 94305, USA

  7J.M.V and W.J.S. contributed equally to this work.

  8Correspondence should be addressed to J.R.B.

At least five adult−onset neurodegenerative diseases, including Huntington disease (HD), and dentatorubral−pallidoluysian atrophy (DRPLA) are produced by genes containing a variably increased CAC repeat within the coding region1−4. The size range of the repeats is similar in all diseases; unaffected individuals have fewer than 30 CAG repeats, whereas affected patients usually have more than 40 repeats. The size of the inherited CAG repeat correlates with the severity and age of disease onset1,5−7. The CAG triplet repeat produces a polyglutamine domain in the expressed proteins3,8−10. All of these diseases are inherited in a dominant fashion, and a pathologic gain of function in gene carriers has been proposed. We sought to identify proteins in the brain that selectively interact with polyglutamine−domain proteins, hypothesizing that the polyglutamine domain may determine protein−protein interactions.

REFERENCES
  1. Koide, R. et al. Unstable expansion of CAG repeat in hereditary dentatorubralpallidoluysian atrophy (DRPLA). Nature Genet. 6, 9−13 (1994). | Article | PubMed  | ISI | ChemPort |
  2. Nagafuchi, S. et al. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nature Genet. 6, 14−18 (1994). | Article | PubMed  | ISI | ChemPort |
  3. Huntington's Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72, 971−983 (1993). | PubMed  | ISI |
  4. Willems, P.J. Dynamic mutations hit double figures. Nature Genet. 8, 213−215 (1994). | Article | PubMed  | ISI | ChemPort |
  5. Andrew, S.E. et al. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nature Genet. 4, 398−403 (1993). | Article | PubMed  | ISI | ChemPort |
  6. Ranum, L.P.W. et al. Molecular and clinical correlations in spinocerebellar ataxia type I—evidence for familial effects on the age at onset. Am. J. Hum. Genet. 55, 244−252 (1994). | PubMed  | ISI | ChemPort |
  7. Kawaguchi, Y. et al. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nature Genet. 8, 221−227 (1994). | Article | PubMed  | ISI | ChemPort |
  8. Nagafuchi, S. et al. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nature Genet. 8, 177−182 (1994). | Article | PubMed  | ISI | ChemPort |
  9. Jou, Y.S. & Myers, R.M. Evidence from antibody studies that the CAG repeat in the Huntington disease gene is expressed in the protein. Hum. Mol. Genet. 4, 465−469 (1995). | PubMed  | ISI | ChemPort |
  10. La Spada, A.R., Wilson, E.M., Lubahn, D.B., Harding, A.E. & Fischbeck, K.H. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352, 77−79 (1991). | Article | PubMed  | ISI | ChemPort |
  11. Yazawa, I. et al. Abnormal gene product identified in hereditary dentatorubralpallidoluysian atrophy (DRPLA) brain. Nature Genet. 10, 99−103 (1995). | Article | PubMed  | ISI | ChemPort |
  12. Meyer-Siegler, K. et al. A human nuclear uracil DNA glycosylase is the 37-kDa subunit of glyceraldehyde-3-phosphate dehydrogenase. Proc. Natl. Acad. Sci. USA 88, 8460−8464 (1991). | PubMed  | ChemPort |
  13. Beal, M.F. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses? Ann. Neurol. 31, 119−130 (1992). | PubMed  | ISI | ChemPort |
  14. Nagy, E. & Rigby, W.F. Glyceraldehyde-3-phosphate dehydrogenase selectively binds AU-rich RNA in the NAD(+)-binding region (Rossmann fold). J. Biol. Chem. 270, 2755−2763 (1995). | Article | PubMed  | ISI | ChemPort |
  15. Nakai, A., Satoh, M., Hirayoshi, K. & Nagata, K. Identification of the ATP-binding heat-inducible protein of MR = 37,000 as glyceraldehyde-3-phosphate dehydrogenase. Biochem. Biophys. Res. Commun. 176, 59−64 (1991). | PubMed  | ISI | ChemPort |
  16. Zeng, F.Y., Gerke, V. & Gabius, H.J. Identification of annexin II, annexin VI and glyceraldehyde-3-phosphate dehydrogenase as calcyclin-binding proteins in bovine heart. Int. J. Blochem. 25, 1019−1027 (1993). | Article | ChemPort |
  17. Mejean, C., Pons, F., Benyamin, Y. & Roustan, C. Antigenic probes locate binding sites for the glycolytic enzymes glyceraldehyde-3-phosphate dehydrogenase, aldolase and phosphofructokinase on the actin monomer in microfilaments. Biochem. J. 264, 671−677 (1989). | PubMed  | ISI | ChemPort |
  18. Somers, M., Engelborghs, Y. & Baert, J. Analysis of the binding of glyceralde-hyde-3-phosphate dehydrogenase to microtubules, the mechanism of bundle formation and the linkage effect. Eur. J. Biochem. 193, 437−444 (1990). | PubMed  | ISI | ChemPort |
  19. Schulze, H. et al. Rat brain glyceraldehyde-3-phosphate dehydrogenase interacts with the recombinant cytoplasmic domain of Alzheimer's beta-amyloid precursor protein. J. Neurochem. 60, 1915−1922 (1993). | PubMed  | ISI | ChemPort |
  20. Perutz, M.F., Johnson, T., Suzuki, M. & Finch, J.T. Glutamine repeats as polar zippers: Their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91, 5355−5358 (1994). | PubMed  | ChemPort |
  21. Stott, K., Blackburn, J.M., Butler, P.J.G. & Perutz, M. Incorporation of glutamine repeats makes protein oligomerize: Implications for neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 92 6509−6513 (1995). | PubMed  | ChemPort |
  22. Roses, A.D. Alzheimer's disease as a model of molecular gerontology. J. Natl. Inst. Health Res. 7 51−57 (1995).
  23. Trottier, Y. et al. Cellular localization of the Huntington's disease protein and discrimination of the normal and mutated form. Nature Genet. 10, 104−110 (1995). | Article | PubMed  | ISI | ChemPort |
  24. Sharp, A.H. et al. Widespread expression of Huntingtons disease gene (IT15) protein product. Neuron 14, 1065−1074 (1995). | PubMed  | ISI | ChemPort |
  25. DiFiglia, M. et al. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14, 1075−1081 (1995). | PubMed  | ISI | ChemPort |
  26. van Tuinen, E. & Riezman, H. Immunolocalization of glyceraldehyde-3-phosphate dehydrogenase, hexokinase, and carboxypeptidase Y in yeast cells at the ultrastructural level. J. Histochem. Cytochem. 35, 327−333 (1987). | PubMed  | ChemPort |
  27. Minaschek, G., Groschel-Stewart, U., Blum, S. & Bereiter-Hahn, J. Microcompartmentation of glycolytic enzymes in cultured cells. Eur. J. Cell Biol. 58, 418−428 (1992). | PubMed  | ISI | ChemPort |
  28. Ronai, Z. Glycolytic enzymes as DNA binding proteins. Int. J. Biochem. 25, 1073−1076 (1993). | Article | PubMed  | ISI | ChemPort |
  29. Morgenegg, G. et al. Glyceraldehyde-3-phosphate dehydrogenase is a nonhistone protein and a possible activator of transcription in neurons. J. Neurochem. 47 54−62 (1986). | PubMed  | ISI | ChemPort |
  30. Knull, H.R. & Fillmore, S.J. Glycolytic enzyme levels in synaptosomes. Comp. Biochem. Physiol. [B] 81, 349−351 (1985). | Article | PubMed  | ISI | ChemPort |
  31. Hoogeveen, A.T. et al. Characterization and localization of the Huntington disease gene product. Hum. Mol. Genet. 2 2069−2073 (1993). | PubMed  | ISI | ChemPort |
  32. Servadio, A. et al. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nature Genet. 10, 94−98 (1995). | Article | PubMed  | ISI | ChemPort |
 Top
 Top
Abstract
Previous | Next
Table of contents
Download PDFDownload PDF
Send to a friendSend to a friend
Save this linkSave this link

Open Innovation Challenges

naturejobs

References
Export citation
Export references
natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Medicine
ISSN: 1078-8956
EISSN: 1546-170X
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | Focuses | For authors | Online submission | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | Reprints and permissions | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1996 Nature Publishing Group | Privacy policy